Get Full access to Top 1000 data, subscribe from only €29

Register Now »

Sanofi Genzyme

Sanofi Genzyme is a pharmaceutical company and its products and services are focused on areas such as rare inherited disorders, kidney disease, cancer, transplant and immune disease. Established in 2001, Genzyme Waterford is situated on a 37-acre site in Waterford. This multi-phased biopharmaceutical facility has seen capital investment of over €500 million. It is a state-of-the-art facility that serves patients across more than 70 countries. Additional products continue to be developed and introduced to the site with the current expansion set to bring the first Sanofi insulin products to the facility. Since Sanofi’s acquisition of Genzyme in 2011, the Waterford site has become more closely aligned with the Sanofi network in Europe .

Financial Data


By Turnover

(€1.6 billion)

By Employees

52nd in Top Companies By Turnover
  • 490
  • €1.6 billion


  • Ruth Beadle General Manager

Latest News


Thanks, You are now signed up to the Top 1000 newsletter!